Abstract

Pleomorphic adenoma gene 1 (PLAG1) is a transcription factor involved in cancer and growth. We discovered a de novo DNA motif containing a PLAG1 binding site in the promoters of genes activated during zygotic genome activation (ZGA) in human embryos. This motif was located within an Alu element in a region that was conserved in the murine B1 element. We show that maternally provided Plag1 is needed for timely mouse preimplantation embryo development. Heterozygous mouse embryos lacking maternal Plag1 showed disrupted regulation of 1,089 genes, spent significantly longer time in the 2-cell stage, and started expressing Plag1 ectopically from the paternal allele. The de novo PLAG1 motif was enriched in the promoters of the genes whose activation was delayed in the absence of Plag1. Further, these mouse genes showed a significant overlap with genes upregulated during human ZGA that also contain the motif. By gene ontology, the mouse and human ZGA genes with de novo PLAG1 motifs were involved in ribosome biogenesis and protein synthesis. Collectively, our data suggest that PLAG1 affects embryo development in mice and humans through a conserved DNA motif within Alu/B1 elements located in the promoters of a subset of ZGA genes.

Details

Title
Pleomorphic Adenoma Gene 1 Is Needed For Timely Zygotic Genome Activation and Early Embryo Development
Author
Elo, Madissoon 1   VIAFID ORCID Logo  ; Damdimopoulos Anastasios 2 ; Katayama Shintaro 1 ; Krjutškov Kaarel 3 ; Einarsdottir Elisabet 4 ; Mamia Katariina 5 ; De Groef Bert 6   VIAFID ORCID Logo  ; Hovatta Outi 5 ; Kere Juha 7   VIAFID ORCID Logo  ; Damdimopoulou Pauliina 8 

 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 Karolinska Institutet, Bioinformatics and Expression Analysis core facility, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 Competence Centre on Health Technologies, Tartu, Estonia (GRID:grid.487355.8); University of Helsinki and Folkhälsan Institute of Genetics, Molecular Neurology Research Program, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); University of Helsinki and Folkhälsan Institute of Genetics, Molecular Neurology Research Program, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Intervention and Technology, Karolinska Institutet, Department of Clinical Science, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 La Trobe University, Department of Physiology, Anatomy and Microbiology, Victoria, Australia (GRID:grid.1018.8) (ISNI:0000 0001 2342 0938) 
 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); University of Helsinki, and Folkhälsan Institute of Genetics, Research Programs Unit, Molecular Neurology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); King’s College London, Guy’s Hospital, School of Basic and Medical Biosciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Intervention and Technology, Karolinska Institutet, Department of Clinical Science, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2237860220
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.